130 related articles for article (PubMed ID: 23105376)
1. Separation of antihemophilic factor VII from human plasma by column chromatography.
Baikar VM; Kamath MV; Vishwanathan C; Varadkar AM; Bharmal SE
Indian J Clin Biochem; 2003 Jan; 18(1):80-6. PubMed ID: 23105376
[TBL] [Abstract][Full Text] [Related]
2. Direct capture of plasma factor VIII:C by ion exchange chromatography.
Teh LC; Froger M
Vox Sang; 1994; 67(1):8-13. PubMed ID: 7975461
[TBL] [Abstract][Full Text] [Related]
3. A highly purified factor VIII:c concentrate prepared from cryoprecipitate by ion-exchange chromatography.
Burnouf T; Burnouf-Radosevich M; Huart JJ; Goudemand M
Vox Sang; 1991; 60(1):8-15. PubMed ID: 1905084
[TBL] [Abstract][Full Text] [Related]
4. Non-Cryoprecipitation Separation of Coagulation FVIII and Prothrombin Complex Proteins by Pseudoaffinity Calcium Elution Chromatography Using Anion Exchange Resin.
Feliciano GP; Arimori SH; Nakao VW; Dos Santos JR; Martins EAL; Bemquerer MP; Cheng E
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297304
[TBL] [Abstract][Full Text] [Related]
5. Purification of factor VIII/von Willebrand factor from human plasma on immobilized lentil lectin.
Zhou FL; Burnouf-Radosevich M; Burnouf T
Protein Expr Purif; 1994 Apr; 5(2):138-43. PubMed ID: 8054845
[TBL] [Abstract][Full Text] [Related]
6. Purification of coagulation factor VIII by immobilized metal affinity chromatography.
Rodrigues ES; Verinaud CI; Oliveira DS; Raw I; Lopes AP; Martins EA; Cheng E
Biotechnol Appl Biochem; 2015; 62(3):343-8. PubMed ID: 25082654
[TBL] [Abstract][Full Text] [Related]
7. Large-scale purification of factor VIII by affinity chromatography: optimization of process parameters.
te Booy MP; Faber A; de Jonge E; Wolterink EP; Riethorst W; Beugeling T; Bantjes A; Over J; König BW
J Chromatogr; 1990 Mar; 503(1):103-14. PubMed ID: 2111329
[TBL] [Abstract][Full Text] [Related]
8. Progress in large-scale purification of factor VIII/von Willebrand factor concentrates using ion-exchange chromatography.
Mori F; Nardini I; Rossi P; Nardini C; Farina C
Vox Sang; 2008 Nov; 95(4):298-307. PubMed ID: 19138259
[TBL] [Abstract][Full Text] [Related]
9. Preparation of intermediate-purity factor VIII concentrate by direct gel filtration of cryoprecipitate.
Teh LC
Vox Sang; 1993; 65(4):251-7. PubMed ID: 8310677
[TBL] [Abstract][Full Text] [Related]
10. Purification of coagulation factor VIII using chromatographic methods. Direct chromatography of plasma in anion exchange resins.
Cheng E; Jinzenji D; Lorthiois AP; de Carvalho RR; Tanaka-Azevedo AM; Raw I; Martins EA
Biotechnol Lett; 2010 Sep; 32(9):1207-14. PubMed ID: 20431912
[TBL] [Abstract][Full Text] [Related]
11. [Separation of coagulation factor VIII with high activity using gigaporous anion exchange chromatography].
Kang L; Zhang Y; Luo J; Li Y; Zhou Y; Yu R; Su Z
Se Pu; 2012 Jun; 30(6):618-23. PubMed ID: 23016297
[TBL] [Abstract][Full Text] [Related]
12. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
Mazurier C; Samor B; Deromeuf C; Goudemand M
Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
[TBL] [Abstract][Full Text] [Related]
13. Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate.
Burnouf-Radosevich M; Burnouf T
Vox Sang; 1992; 62(1):1-11. PubMed ID: 1580062
[TBL] [Abstract][Full Text] [Related]
14. Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma.
Hornsey VS; Krailadsiri P; MacDonald S; Seghatchian J; Williamson LM; Prowse CV
Br J Haematol; 2000 Jun; 109(3):665-70. PubMed ID: 10886222
[TBL] [Abstract][Full Text] [Related]
15. Quantification of coagulation factor VIII in human plasma with liquid chromatography tandem mass spectrometry using a selective sample purification with camelid nanobodies.
El Amrani M; Donners AAM; Graat G; Lentjes EG; Huisman A; Musson REA; van Maarseveen EM
J Pharm Biomed Anal; 2019 Oct; 175():112781. PubMed ID: 31398627
[TBL] [Abstract][Full Text] [Related]
16. Progress in purification of virus-inactivated factor VIII concentrates. Three generations of solvent/detergent treated plasma derivatives.
Schwinn H; Smith A; Wolter D
Arzneimittelforschung; 1989 Oct; 39(10):1302-5. PubMed ID: 2514695
[TBL] [Abstract][Full Text] [Related]
17. Isolation of the factor VIII-von Willebrand factor complex directly from plasma by gel filtration.
Kaersgaard P; Barington KA
J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(2):357-67. PubMed ID: 9792522
[TBL] [Abstract][Full Text] [Related]
18. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the effects of temperature, time and factor VIII assay type on factor VIII activity in cryoprecipitate in Iran.
Omidkhoda A; Tabatabaei MR; Atarodi K; Karimi K; Froushani AR; Pourfathollah AA
Blood Transfus; 2011 Oct; 9(4):394-9. PubMed ID: 21839017
[TBL] [Abstract][Full Text] [Related]
20. Purification of factor VIII and von Willebrand factor from human plasma by anion-exchange chromatography.
Josic D; Schwinn H; Stadler M; Strancar A
J Chromatogr B Biomed Appl; 1994 Dec; 662(2):181-90. PubMed ID: 7719474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
